Bunge Investing Cash Flow increased by 96.6% to -$182.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.0%, from -$280.00M to -$182.00M. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows a downward trend with a -39.8% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.28B | $1.28B | $1.28B | $1.62B | $1.62B | $1.62B | $1.62B | $45.00M | -$429.00M | -$262.00M | -$363.00M | -$396.00M | -$152.00M | -$409.00M | -$157.00M | -$280.00M | -$5.42B | -$182.00M |
| QoQ Change | — | +0.0% | +0.0% | +27.1% | +0.0% | +0.0% | +0.0% | -97.2% | <-999% | +38.9% | -38.5% | -9.1% | +61.6% | -169.1% | +61.6% | -78.3% | <-999% | +96.6% |
| YoY Change | — | — | — | — | +27.1% | +27.1% | +27.1% | -97.2% | -126.4% | -116.1% | -122.3% | -980.0% | +64.6% | -56.1% | +56.7% | +29.3% | <-999% | +35.0% |